Conflixis – a data and risk intelligence company – announced $4.2 million in seed capital co-led by Lerer Hippeau and Origin Ventures, with additional investment from mark vc, Springtime Ventures, and continued support from early investor Crētiv Capital.
This new funding round will advance Conflixis’ goals of improving the healthcare ecosystem by ensuring that every financial relationship is contextualized and that its influence on procurement, operational, and medical decisions is understood.
Conflixis has created a unified platform that combines traditional COI management functionality with proprietary risk models and advanced analytics, enabling some of the largest health systems and practice groups with unparalleled insight into how even the most complex relationships influence their decisions.
This funding will further accelerate the platform’s growth by dramatically expanding Conflixis’ library of evidence-based influence models, including predictive spend capabilities powered by peer-reviewed data. And the investment and attention will also be placed on expanding Conflixis’ client-facing and research and development teams.
KEY QUOTES:
“The Conflixis Platform helps large healthcare organizations identify and understand the role that conflicting financial relationships play in medical and operational decisions. Collaboration between healthcare providers, innovators, and industry is absolutely critical for continued technological and scientific advancement. Transparency around these relationships is good for all stakeholders and will result in better decision-making at healthcare organizations of all kinds.”
- CEO Aaron Narva
“We are excited to partner with Aaron and team as they tackle the massive issue of illuminating conflicts of interest in healthcare. In a single year, Conflixis has demonstrated product market fit across a range of healthcare stakeholders, including major health systems and large practice groups. This next tranche of funding will give Conflixis the opportunity to execute on their roadmap and continue to drive growth, for the benefit of patients, payers, and large healthcare organizations, alike.”
- Graham Brown, Managing Partner at Lerer Hippeau
“We see a tremendous opportunity in using data for smarter decision-making in healthcare. Conflixis is at the forefront of this transformation, providing innovative solutions that address critical challenges in conflicts management.”
- Jacquie Marshall Siegmund, Principal at Origin Ventures
“We have had a front row seat to Conflixis’ fast-growing position in a market ripe for change. The Conflixis platform goes way beyond compliance – rethinking the value of financial transparency to the bottom lines of healthcare organizations – and, more importantly – to the long-term impacts on patient outcomes.”
- Noah Zaltz, Co-Founder and Managing Partner at Crētiv Capital
